Aurenar is creating a unique, disposable, wearable neuromodulation device that is changing the arc of care of critically ill patients.

Fluid Biomed is commercializing the first polymer-based brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke. The company team of neurosurgeons, scientists, and engineers has designed the world’s first hybrid polymer-metal flow-diverting stent to cure this deadly disease.

Creating a bridge between humans and machines for the enhancement of people’s lives.

Comprehensive virtual care for people who have experienced a stroke. Precision Recovery is helping patients feel safe, connected and in control of their recovery from the comfort of their home.

Proprio is a technology company modernizing the way we predict, perform, and perfect surgery through the combination of physician expertise and immersive, intelligent technology.

A breakthrough technology to directly restore shoulder, arm, and hand movement for stroke survivors.

Von Vascular, Inc. is at the forefront of medical device innovation, dedicated to transforming thrombectomy with groundbreaking technologies.

Radical is reinventing the neurovascular catheter with a novel “ribbon” construction that delivers flexibility, pushability, and stability at once - reaching further into tortuous anatomy without compromise.

A Cornell nanomedicine spinout, TETmedical is building NSE-FAST - a first-of-its-kind blood-based diagnostic to detect brain injury from stroke, powered by its tethered-enzyme “nanobot.”

Hyperion is bringing AI-guided, robot-assisted precision to one of medicine’s most common
procedures - its IVY platform performed the world’s first robotic-assisted IV catheterization.

Enso Vascular is developing a first-of-its-kind topical patch that prepares the vascular access site before needle insertion - minimizing pain and reducing vessel spasm and access complications across hundreds of millions of procedures.